Patent application number | Description | Published |
20090304824 | Rapid-Melt Compositions, Methods of Making Same and Methods of Using Same - A novel rapid-melt composition, including methods of making the same, and methods of using the same for the delivery of prophylactic and therapeutic active materials to a mammal. The rapid-melt compositions are formed by molding or compression, with an additional heating step being preferred. | 12-10-2009 |
20100010101 | Rapid-Melt Compositions and Methods of Making Same - The present invention provides a novel rapid-melt pharmaceutical composition comprising a binder, a super emulsifier, a diluent/bulking material; and an active ingredient. The present invention also provides a rapid-melt bead composition comprising a binder having a melting point from about 20 to about 90° C., an emulsifier; a diluent/bulking material; and an active ingredient. Further, the present invention provides a chew tablet composition comprising a binder; an emulsifier having a melting point of greater than about 40° C.; a diluent/bulking material; and an active ingredient. Methods of making the disclosed compositions are also described. | 01-14-2010 |
20100196466 | DRUG DELIVERY SYSTEM - A novel encapsulated product is provided and includes: at least one pharmaceutical; at least one compressible material; and at least one tableting material; wherein the encapsulated product is in the form of a caplet having a diameter of from about 1 millimeter to about 7 millimeters and a length from about 1 millimeter to about 7 millimeters. A method for preparing the encapsulated product is also provided. | 08-05-2010 |
20110061345 | SOLID AND SEMI-SOLID DOSAGE FORMS AND SYSTEMS AND METHODS FOR FORMING AND PACKAGING THEREOF - The present invention relates to a pharmaceutical dosage form, and methods and system for making the pharmaceutical dosage form. The pharmaceutical dosage form contains a first component and a second component sealed in a container, such as a packet or sachet, blister pack, and capsule. Machines and methods for making the pharmaceutical dosage form is also provided. | 03-17-2011 |
Patent application number | Description | Published |
20090017110 | MODIFIED RELEASE FORMULATIONS OF ANTI-IRRITABILITY DRUGS - Modified or extended release formulations containing mesalamine compounds and associated methods are disclosed and described. In some aspects, such formulations may be substantially bioequivalent to known FDA approved mesalamine formulations such as PENTASA®. | 01-15-2009 |
20090130208 | Modified release niacin formulations - Modified release niacin formulations, methods for making the formulations, and methods of using the formulations. | 05-21-2009 |
20090136550 | MODIFIED RELEASE FORMULATIONS OF DILTIAZEM - Modified release diltiazem compositions and associated methods of preparation and administration are provided. | 05-28-2009 |
20090285889 | MODIFIED RELEASE FORMULATIONS OF DIHYDROPYRIDINE COMPOUNDS AND METHODS OF MAKING SAME - The invention relates to a modified release (e.g., extended release) tablet composition for oral administration comprising: (a) a dihydropyridine compound or a prodrug or salt thereof; (b) a first release control agent; (c) a second release control agent; and (d) a third release control agent; wherein said second release control agent has a higher viscosity than said first release control agent. The invention also relates to methods for making such modified release (e.g., extended release) tablet compositions. After tableting, such compositions exhibit a release profile that is approximately zero order without the need of a coating. | 11-19-2009 |
20090311317 | MODIFIED RELEASE TOLTERODINE FORMULATIONS - Modified or extended release formulations containing tolterodine and associated methods are disclosed and described. Methods for making and administering said modified release formulations are also disclosed. | 12-17-2009 |
20130071476 | Rapid Melt Controlled Release Taste-Masked Compositions - Rapid melt tablets that dissolve and release an active component in the oral cavity are comprised of a pharmaceutical active ingredient such as dextromethorphan complexed with a resin that is effective in taste-masking the otherwise bitter taste of the active making it convenient for oral administration. The drug/resin-complexed particles can be coated with water swellable or water insoluble polymers to impart controlled release properties to the active ingredient. A rapid melt tablet also comprises diluents, sweeteners, flavors, disintegrants and other excipients to form granules that can be compressed into tablets at low pressure without the need for a binding agent. | 03-21-2013 |
20140099378 | Modified Release Formulations of Anti-Irritability Drugs - Modified or extended release formulations containing mesalamine compounds and associated methods are disclosed and described. In some aspects, such formulations may be substantially bioequivalent to known FDA approved mesalamine formulations such as PENTASA®. | 04-10-2014 |